Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

Zheng, Yajuan; Zhong, Guansheng; Yu, Kun; Lei, Kefeng; Yang, Qiong

doi:10.3389/fonc.2020.00482

CORRECTION article

Front. Oncol. , 09 April 2020

Sec. Surgical Oncology

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.00482

Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

This article is a correction to:

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
1. Read original article

$\nYajuan Zheng$ Yajuan Zheng¹

Guansheng Zhong²

Kun Yu¹

Kefeng Lei^1,3^*

Qiong Yang¹^*

¹Department of Breast and Thyroid Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China
²Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
³Department of General Surgery, The 7th Affiliated Hospital of Sun Yat-sen University, Shenzhen, China

A Corrigendum on
Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

by Zheng, Y., Zhong, G., Yu, K., Lei, K., and Yang, Q. (2020). Front. Oncol. 10:148. doi: 10.3389/fonc.2020.00148

In the published article, there was an error regarding the affiliation for “Kefeng Lei.” As well as having 3, Kefeng Lei should also have affiliation 1. In addition, there was a mistake in the order of corresponding authors. The first corresponding author should be Qiong Yang.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: metastatic breast cancer, nomogram, SEER program, prognosis, clinic utility

Citation: Zheng Y, Zhong G, Yu K, Lei K and Yang Q (2020) Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer. Front. Oncol. 10:482. doi: 10.3389/fonc.2020.00482

Received: 24 February 2020; Accepted: 17 March 2020;
Published: 09 April 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Zheng, Zhong, Yu, Lei and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qiong Yang, eWFuZ3Fpb25nQGhtYy5lZHUuY24=; Kefeng Lei, czc4MjkzQDE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

95% of researchers rate our articles as excellent or good

95% of researchers rate our articles as excellent or good